Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson’s Disease: The ICICLE-PD Study
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Background: Cognitive decline is a frequent complication of Parkinson’s disease (PD) and the identification of predictive biomarkers for it would help in its management. Objective: Our aim was to analyse whether senescence markers (telomere length, p16 and p21) or their change over time could help to better predict cognitive and motor progression of newly diagnosed PD patients. We also compared these senescence markers to previously analysed markers of inflammation for the same purpose. Methods: This study examined the association of blood-derived markers of cell senescence and inflammation with motor and cognitive function over time in an incident PD cohort (the ICICLE-PD study). Participants (154 newly diagnosed PD patients and 99 controls) underwent physical and cognitive assessments over 36 months of follow up. Mean leukocyte telomere length and the expression of senescence markers p21 and p16 were measured at two time points (baseline and 18 months). Additionally, we selected five inflammatory markers from existing baseline data. Results: We found that PD patients had shorter telomeres at baseline and 18 months compared to age-matched healthy controls which also correlated to dementia at 36 months. Baseline p16 levels were associated with faster rates of motor and cognitive decline over 36 months in PD cases, while a simple inflammatory summary score at baseline best predicted cognitive score over this same time period in PD patients. Conclusion: Our study suggests that both inflammatory and senescence markers (p16) are valuable predictors of clinical progression in PD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders · doi:10.1002/mds.22340 · Cited by 7,536
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams‐Gray, C. H., et al. (2012) · Movement Disorders · doi:10.1002/mds.24893 · Cited by 2,609
Self-citationOxidative stress shortens telomeres
von Zglinicki, T. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02110-2 · Cited by 2,524 · cited 1×
“Importantly, telomeres are 55 susceptible to oxidative stress [9] and can be indi56 cators of ongoing disease processes in the brain.”
Ink4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486
Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Bussian, T. J., Aziz, A., Meyer, C. F., Swenson, B. L., van Deursen, J. M., & Baker, D. J. (2018) · Nature · doi:10.1038/s41586-018-0543-y · Cited by 1,289
The signals and pathways activating cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.013 · Cited by 1,046 · cited 1×
“Cellular senescence is a response to stress (including shortened or damaged telomeres) characterized by an irreversible cell cycle arrest, a pro-inflammatory secretory phenotype and a number of not entirely specific tumour-suppressor proteins, including the cyclin-dependent kinase inhibitors p21CIP1Waf1 and p16INK4A […”
BackgroundDoes neuroinflammation fan the flame in neurodegenerative diseases?
Frank-Cannon, T. C., Alto, L. T., McAlpine, F. E., & Tansey, M. G. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-47 · Cited by 751
Jurk, D., Wang, C., Miwa, S., Maddick, M., Korolchuk, V., Tsolou, A., Gonos, E. S., Thrasivoulou, C., Jill Saffrey, M., Cameron, K., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00870.x · Cited by 598
Tau protein aggregation is associated with cellular senescence in the brain
Musi, N., Valentine, J. M., Sickora, K. R., Baeuerle, E., Thompson, C. S., Shen, Q., & Orr, M. E. (2018) · Aging Cell · doi:10.1111/acel.12840 · Cited by 595 · cited 1×
“In 100 mice as well as in humans, the neuronal accumulation 101 of neurofibrillary tangles associated with cognitive 102 decline and neuronal loss in Alzheimer’s disease 103 causes a cellular senescence phenotype in the affected 104 neurons [35].”
BackgroundChinta, S. J., Woods, G., Demaria, M., Rane, A., Zou, Y., McQuade, A., Rajagopalan, S., Limbad, C., Madden, D. T., Campisi, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.092 · Cited by 530 · cited 1×
“Importantly, eradication of senescent cells in a 551 mouse model for PD resulted in better motor function, 552 suggesting a therapeutic benefit [60].”
BackgroundAgeing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448 · cited 1×
“senescence suggested their relevance as biomarkers 544 of ageing [37, 58].”
BackgroundBrosseron, F., Krauthausen, M., Kummer, M., & Heneka, M. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8657-1 · Cited by 447
Cellular senescence in renal ageing and disease
Sturmlechner, I., Durik, M., Sieben, C. J., Baker, D. J., & van Deursen, J. M. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.183 · Cited by 345
Arai, Y., Martin-Ruiz, C. M., Takayama, M., Abe, Y., Takebayashi, T., Koyasu, S., Suematsu, M., Hirose, N., & von Zglinicki, T. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.07.029 · Cited by 333
Self-citationCellular senescence and the aging brain
Chinta, S. J., Woods, G., Rane, A., Demaria, M., Campisi, J., & Andersen, J. K. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.018 · Cited by 282
Zhu, Y., Liu, X., Ding, X., Wang, F., & Geng, X. (2019) · Biogerontology · doi:10.1007/s10522-018-9769-1 · Cited by 255 · cited 1×
“Telomere shortening and dysfunction cause 54 cellular senescence [8].”
BackgroundMeta-analysis of Telomere Length in Alzheimer’s Disease
Forero, D. A., González-Giraldo, Y., López-Quintero, C., Castro-Vega, L. J., Barreto, G. E., & Perry, G. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw053 · Cited by 229
Review: a meta‐analysis of GWAS and age‐associated diseases
Jeck, W. R., Siebold, A. P., & Sharpless, N. E. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00871.x · Cited by 204 · cited 1×
“of more than 300 genome wide association studies 91 (GWAS) identified the p16INK4a gene to be linked 92 to the highest number of age-associated pathologies, 93 including several types of cardiovascular diseases, 94 diabetes, glaucoma and AD [28].”
BackgroundTelomere length in Parkinson's disease: A meta-analysis
Forero, D. A., González-Giraldo, Y., López-Quintero, C., Castro-Vega, L. J., Barreto, G. E., & Perry, G. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.01.002 · Cited by 70 · cited 2×
“A recent meta-analysis concluded that there was no association between leukocyte telomere length and incidence of PD [11].”
Pustavoitau, A., Barodka, V., Sharpless, N. E., Torrice, C., Nyhan, D., Berkowitz, D. E., Shah, A. S., Bandeen Roche, K. J., & Walston, J. D. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2015.12.003 · Cited by 36
Hochstrasser, T., Marksteiner, J., Defrancesco, M., Deisenhammer, E. A., Kemmler, G., & Humpel, C. (2011) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000330468 · Cited by 31
Hinterberger, M., Fischer, P., Huber, K., Krugluger, W., & Zehetmayer, S. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1721-z · Cited by 28 · cited 1×
“However, the relationship between shorter telomeres in peripheral blood cells and incident dementia has been reported in the general population [19], in stroke [10], AD [54, 55], Down’s syndrome [56] and in the transition from MCI to dementia [57].”
Background
Research works printed but not linked: 45
- 10.1001/archneur.60.3.387 · DOI · Paper page
- 10.1212/01.wnl.0000242630.52203.8f · DOI · Paper page
- 10.1136/jnnp-2013-305277 · DOI · Paper page
- 10.1002/mds.20216 · DOI · Paper page
- 10.1212/01.WNL.0000036610.36834.E0 · DOI · Paper page
- 10.1016/j.parkreldis.2016.04.009 · DOI · Paper page
- 10.1002/gps.4623 · DOI
- 10.1002/ana.20869 · DOI · Paper page
- 10.1111/ene.12252 · DOI
- 10.1002/mds.21867 · DOI · Paper page
- 10.1093/ageing/aft036 · DOI
- 10.1016/j.neurobiolaging.2008.07.012 · DOI
- 10.1016/j.neurobiolaging.2009.12.006 · DOI · Paper page
- 10.1016/j.neulet.2011.01.041 · DOI
- 10.1016/j.neurobiolaging.2010.11.013 · DOI
- 10.1001/archneurol.2012.1541 · DOI · Paper page
- 10.1186/1471-2318-10-62 · DOI
- 10.3109/01677063.2011.651665 · DOI
- 10.1007/s12603-010-0275-7 · DOI
- 10.1371/journal.pone.0113387 · DOI · Paper page
- 10.1093/gerona/glq125 · DOI
- 10.1093/gerona/63.5.467 · DOI
- 10.1016/j.neurobiolaging.2011.05.022 · DOI
- 10.1016/j.mehy.2009.02.047 · DOI
- 10.1378/chest.15-0645 · DOI
- 10.1002/mds.26563 · DOI · Paper page
- 10.3389/fphys.2018.00706 · DOI · Paper page
- 10.1016/j.arr.2015.11.006 · DOI · Paper page
- 10.1212/WNL.0b013e31827deb74 · DOI · Paper page
- 10.1212/WNL.0000000000000066 · DOI · Paper page
- 10.1136/jnnp.55.3.181 · DOI · Paper page
- 10.1016/0022-3956(75)90026-6 · DOI · Paper page
- 10.1111/j.1532-5415.2005.53221.x · DOI · Paper page
- 10.1212/WNL.17.5.427 · DOI · Paper page
- 10.1002/mds.23429 · DOI · Paper page
- 10.1002/mds.27813 · DOI
- 10.1002/ajmg.b.32575 · DOI
- 10.1016/j.neurobiolaging.2008.05.016 · DOI
- 10.1186/s12868-017-0367-y · DOI
- 10.1186/s12974-018-1206-5 · DOI
- 10.1016/j.neulet.2012.03.093 · DOI
- 10.1111/j.1474-9726.2009.00489.x · DOI · Paper page
- 10.1186/s12974-017-0935-1 · DOI · Paper page
- 10.1001/jamaneurol.2016.2742 · DOI · Paper page
- 10.1007/s12035-017-0404-y · DOI
Cited by
A Senescence-Centric View of Aging: Implications for Longevity and Disease
Borghesan, M., Hoogaars, W. M. H., Varela-Eirin, M., Talma, N., & Demaria, M. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.07.002 · Cited by 267
Wan, T., Weir, E. J., Johnson, M., Korolchuk, V. I., & Saretzki, G. C. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101953 · Cited by 52
“It eventually can even result in Parkinson ’ s disease related dementia (PDD).”
BackgroundInfluentialSelf-citationIdentification of distinct and age‐dependent p16High microglia subtypes
Talma, N., Gerrits, E., Wang, B., Eggen, B. J. L., & Demaria, M. (2021) · Aging Cell · doi:10.1111/acel.13450 · Cited by 46
Age-Related Adaptive Immune Changes in Parkinson’s Disease
Kouli, A., & Williams-Gray, C. H. (2022) · Journal of Parkinson's Disease · doi:10.3233/jpd-223228 · Cited by 20
Self-citation
Metadata
- Authors
- Martin-Ruiz, C., Williams-Gray, C. H., Yarnall, A. J., Boucher, J. J., Lawson, R. A., Wijeyekoon, R. S., Barker, R. A., Kolenda, C., Parker, C., Burn, D. J., Von Zglinicki, T., & Saretzki, G.
- Venue
- Journal of Parkinson’s Disease
- Publisher
- SAGE Publications
- Published
- 2019-12-16
- Volume
- 10
- Issue
- 1
- Pages
- 193-206
- ISSN
- 1877-7171 (ISSN-L)
- 1877-718X
- OpenAlex
- W2980634970
- Cited by
- 58
- References
- 23
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.